These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6176184)

  • 1. Mechanism of antiviral action of quercetin against cardiovirus infection in mice.
    Veckenstedt A; Pusztai R
    Antiviral Res; 1981 Nov; 1(4):249-61. PubMed ID: 6176184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic action of quercetin and murine alpha/beta interferon in the treatment of Mengo virus infection in mice.
    Veckenstedt A; Güttner J; Béládi I
    Antiviral Res; 1987 Mar; 7(3):169-78. PubMed ID: 3038013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of quercetin on the course of mengo virus infection in immunodeficient and normal mice. A histologic study.
    Güttner J; Veckenstedt A; Heinecke H; Pusztai R
    Acta Virol; 1982 May; 26(3):148-55. PubMed ID: 6127014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice against infection with wild-type Mengo virus and an interferon sensitive mutant (IS-1) by polynucleotides and interferons.
    Stebbing N
    J Gen Virol; 1979 Jul; 44(1):255-60. PubMed ID: 227997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for macrophages for interferon to be effective against encephalomyocarditis virus infection of mice.
    Stebbing N; Dawson KM; Lindley IJ
    Infect Immun; 1978 Jan; 19(1):5-11. PubMed ID: 203537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral action of trehalose dimycolate against EMC virus: role of macrophages and interferon alpha/beta.
    Guillemard E; Geniteau-Legendre M; Mabboux B; Poilane I; Kergot R; Lemaire G; Petit JF; Labarre C; Quero AM
    Antiviral Res; 1993 Oct; 22(2-3):201-13. PubMed ID: 7506511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of a thymic factor in experimental viral infections. I. Thymic hormonal effect on survival, interferon production and NK cell activity in Mengo virus-infected mice.
    Klein AS; Fixler R; Shoham J
    J Immunol; 1984 Jun; 132(6):3159-63. PubMed ID: 6202776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on the relative antiviral efficacies of interferons induced by poly I:C and Mengo virus.
    Campbell JB
    Can J Microbiol; 1976 May; 22(5):712-8. PubMed ID: 179687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of viral replication in cell cultures treated with prostaglandin E1.
    Giron DJ
    Proc Soc Exp Biol Med; 1982 May; 170(1):25-8. PubMed ID: 6177007
    [No Abstract]   [Full Text] [Related]  

  • 10. 3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis.
    Castrillo JL; Vanden Berghe D; Carrasco L
    Virology; 1986 Jul; 152(1):219-27. PubMed ID: 3012868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclosporine on encephalomyocarditis virus infection in mice.
    Zhang XQ; Ho M
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):72-8. PubMed ID: 2848238
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissociable antiviral activities directed against cardioviruses are expressed in L cells treated with interferon.
    Monahan SJ; Simon E
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2299-303. PubMed ID: 1383407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of high doses of potentially antiviral agents to prevent death in virus-infected mice.
    Veckenstedt A; Güttner J; Béládi I
    Acta Virol; 1985 May; 29(3):216-24. PubMed ID: 2864822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing of antiviral compounds against Mengo virus infection of mice. I. Screening of compounds and statistical evaluation of their effects.
    Veckenstedt A; Horn M
    Chemotherapy; 1974; 20(4):235-44. PubMed ID: 4370429
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.
    Stebbing N; Grantham CA; Carey NH
    J Gen Virol; 1976 Jan; 30(1):21-39. PubMed ID: 173799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of encephalomyocarditis virus-induced diabetes in mice by antiviral agents.
    Powers RD; Dotson WM; Hayden FG
    Antiviral Res; 1983 Sep; 3(3):151-9. PubMed ID: 6197026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural antiviral activity of mouse macrophages against encephalomyocarditis virus.
    Soldateschi D; Boraschi D; Tagliabue A
    Antiviral Res; 1985 Aug; 5(4):217-27. PubMed ID: 2994562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of prophylactic effect of statolon against mengovirus in mice.
    Schmidt JP; Pindak FF
    Appl Microbiol; 1968 Mar; 16(3):468-9. PubMed ID: 4297000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
    Werner GH; Jasmin C; Chermann JC
    J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of flavonoids on combined experimental infections with EMC virus and Staphylococcus aureus in mice.
    Panasiak W; Wleklik M; Oraczewska A; Luczak M
    Acta Microbiol Pol; 1989; 38(2):185-8. PubMed ID: 2482663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.